Author details

Full Name

Danielle M Gerlag

Affiliation

ORCID

Career Start Year

2000

Papers

127

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35203534	Impact of Adalimumab Treatment on Interleukin-17 and Interleukin-17 Receptor Expression in Skin and Synovium of Psoriatic Arthritis Patients with Mild Psoriasis.	Biomedicines	2022
35406668	Increased Frequency of CD4 Follicular Helper T and CD8 Follicular T Cells in Human Lymph Node Biopsies during the Earliest Stages of Rheumatoid Arthritis.	Cells	2022
33968050	Novel Insights Into Rheumatoid Arthritis Through Characterization of Concordant Changes in DNA Methylation and Gene Expression in Synovial Biopsies of Patients With Differing Numbers of Swollen Joints.	Front Immunol	2021
32784936	Human Lymph Node Stromal Cells Have the Machinery to Regulate Peripheral Tolerance during Health and Rheumatoid Arthritis.	International Journal of Molecular Sciences	2020
31196657	Nomenclature for the Phases of the Development of Rheumatoid Arthritis.	Clinical Therapeutics	2019
31858293	Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand F-GE-180 and comparison with F-FDG and DCE-MRI.	EJNMMI Research	2019
31749806	Phenotypic Analysis of Human Lymph Nodes in Subjects With New-Onset Type 1 Diabetes and Healthy Individuals by Flow Cytometry.	Frontiers in Immunology	2019
30504445	Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study.	Annals of the Rheumatic Diseases	2019
30649469	Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis.	Rheumatology	2019
31481955	Molecular Characterization of Human Lymph Node Stromal Cells During the Earliest Phases of Rheumatoid Arthritis.	Frontiers in Immunology	2019
31217169	Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire.	Annals of the Rheumatic Diseases	2019
31330824	Myeloid Dendritic Cells Are Enriched in Lymph Node Tissue of Early Rheumatoid Arthritis Patients but not in At Risk Individuals.	Cells	2019
29379035	Distinctive expression of T cell guiding molecules in human autoimmune lymph node stromal cells upon TLR3 triggering.	Sci Rep	2018
28389989	Single vagus nerve stimulation reduces early postprandial C-peptide levels but not other hormones or postprandial metabolism.	Clinical Rheumatology	2018
29482663	Impaired lymph node stromal cell function during the earliest phases of rheumatoid arthritis.	Arthritis Res Ther	2018
27807638	Hormone, metabolic peptide, and nutrient levels in the earliest phases of rheumatoid arthritis-contribution of free fatty acids to an increased cardiovascular risk during very early disease.	Clinical Rheumatology	2017
28690611	Insight into the Endocrine System and the Immune System: A Review of the Inflammatory Role of Prolactin in Rheumatoid Arthritis and Psoriatic Arthritis.	Frontiers in Immunology	2017
28642278	Rheumatoid arthritis and psoriatic arthritis synovial fluids stimulate prolactin production by macrophages.	Journal of Leukocyte Biology	2017
28935945	Synovial tissue research: a state-of-the-art review.	Nature reviews. Rheumatology	2017
28793332	Stromal cell markers are differentially expressed in the synovial tissue of patients with early arthritis.	PLoS ONE	2017
28790026	Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis.	Annals of the Rheumatic Diseases	2017
28701760	Synovial tissue research: a state-of-the-art review.	Nature reviews. Rheumatology	2017
29255214	Corrigendum: Synovial tissue research: a state-of-the-art review.	Nature reviews. Rheumatology	2017
27428460	Brief Report: Altered Innate Lymphoid Cell Subsets in Human Lymph Node Biopsy Specimens Obtained During the At-Risk and Earliest Phases of Rheumatoid Arthritis.	Arthritis Rheumatol	2017
25187158	Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis.	Ann Rheum Dis	2016
27195110	Human lymph-node CD8(+) T cells display an altered phenotype during systemic autoimmunity.	Clinical and Translational Immunology	2016
27019199	Neo-Epitopes--Fragments of Cartilage and Connective Tissue Degradation in Early Rheumatoid Arthritis and Unclassified Arthritis.	PLoS ONE	2016
27179104	Reduced CLEC9A expression in synovial tissue of psoriatic arthritis patients after adalimumab therapy.	Rheumatology	2016
27211565	Autonomic Dysfunction Precedes Development of Rheumatoid Arthritis: A Prospective Cohort Study.	eBioMedicine	2016
27029006	A Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis Patients.	PLoS ONE	2016
26982569	Smelling the Diagnosis: The Electronic Nose as Diagnostic Tool in Inflammatory Arthritis. A Case-Reference Study.	PLoS One	2016
26473331	Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Pharmacokinetic Modeling: Initial Experience in Patients With Early Arthritis.	Arthritis and Rheumatology	2016
26374913	Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment.	Rheumatology	2016
26108918	A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-Î± treatment of psoriatic arthritis.	Proteomics Clin Appl	2016
27616146	The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation.	Rheumatology	2016
27645315	Lymph node biopsy analysis reveals an altered immunoregulatory balance already during the at-risk phase of autoantibody positive rheumatoid arthritis.	European Journal of Immunology	2016
27721464	Erratum: Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis.	Nat Commun	2016
24936585	Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis.	Annals of the Rheumatic Diseases	2015
25808728	DNA Methylome Signature in Synoviocytes From Patients With Early Rheumatoid Arthritis Compared to Synoviocytes From Patients With Longstanding Rheumatoid Arthritis.	Arthritis Rheumatol	2015
26188879	Intra-articular etanercept treatment in inflammatory arthritis: A randomized double-blind placebo-controlled proof of mechanism clinical trial validating TNF as a potential therapeutic target for local treatment.	Joint Bone Spine	2015
26315149	Prevalence of Anti-Citrullinated Protein Antibodies and IgM Rheumatoid Factor in First-Degree Relatives of Dutch Rheumatoid Arthritis Patients.	Arthritis and Rheumatology	2015
26225917	Expression of Prostaglandin E2 Enzymes in the Synovium of Arthralgia Patients at Risk of Developing Rheumatoid Arthritis and in Early Arthritis Patients.	PLoS ONE	2015
26178282	Single-joint Assessment for the Evaluation of Intraarticular Treatment: Responsiveness and Discrimination of the Composite Change Index.	Journal of Rheumatology	2015
26178280	Nuclear Factor-ÎºB-inducing Kinase Is Expressed in Synovial Endothelial Cells in Patients with Early Arthritis and Correlates with Markers of Inflammation: A Prospective Cohort Study.	Journal of Rheumatology	2015
26338034	Does the multi-biomarker disease activity score have diagnostic value in early rheumatoid arthritis and unclassified arthritis?	Annals of the Rheumatic Diseases	2015
26697019	Discovery of Innovative Therapies for Rare Immune-Mediated Inflammatory Diseases via Off-Label Prescription of Biologics: The Case of IL-6 Receptor Blockade in Castleman's Disease.	Frontiers in Immunology	2015
26670468	Serum Vaspin Levels Are Associated with the Development of Clinically Manifest Arthritis in Autoantibody-Positive Individuals.	PLoS ONE	2015
24297376	MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis.	Annals of the Rheumatic Diseases	2015
25109449	Clock gene expression in different synovial cells of patients with rheumatoid arthritis and osteoarthritis.	Acta Histochemica	2014
25437278	Preclinical inflammatory rheumatic diseases: an overview and relevant nomenclature.	Rheumatic Disease Clinics of North America	2014